Modulation of transthyretin expression

Modulation of transthyretin expression

  • CN 103,038,345 A
  • Filed: 04/29/2011
  • Published: 04/10/2013
  • Est. Priority Date: 04/29/2010
  • Status: Active Application
First Claim
Patent Images

1. one kind comprises the compound that connects the modified oligonucleotide that nucleosides form by 12 to 30, and wherein said connection nucleosides comprises at least 8 continuous kernel bases of the sequence described in the SEQ ID NO:

  • 25,80,86,87,115,120,122 or 124.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×